MARCHIGNOLI, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 1.203
NA - Nord America 678
EU - Europa 491
AF - Africa 58
SA - Sud America 54
Totale 2.484
Nazione #
US - Stati Uniti d'America 663
CN - Cina 374
SG - Singapore 321
VN - Vietnam 196
IT - Italia 161
KR - Corea 91
HK - Hong Kong 72
GB - Regno Unito 56
IN - India 56
DE - Germania 53
FR - Francia 42
BR - Brasile 40
AT - Austria 35
NL - Olanda 34
JP - Giappone 29
SE - Svezia 24
ZA - Sudafrica 21
RU - Federazione Russa 19
SC - Seychelles 18
IE - Irlanda 14
CI - Costa d'Avorio 13
FI - Finlandia 13
IQ - Iraq 11
BD - Bangladesh 9
BG - Bulgaria 8
CH - Svizzera 8
ID - Indonesia 8
CA - Canada 7
AR - Argentina 6
TH - Thailandia 6
EC - Ecuador 5
MX - Messico 5
TR - Turchia 5
JO - Giordania 4
PH - Filippine 4
PL - Polonia 4
SA - Arabia Saudita 4
UA - Ucraina 4
EE - Estonia 3
ES - Italia 3
TW - Taiwan 3
BE - Belgio 2
CO - Colombia 2
DZ - Algeria 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
PK - Pakistan 2
RS - Serbia 2
TG - Togo 2
AO - Angola 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
IR - Iran 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PY - Paraguay 1
RO - Romania 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 2.484
Città #
Singapore 232
Hefei 175
Ashburn 124
Seoul 87
Hong Kong 68
Bologna 55
Ho Chi Minh City 54
Hanoi 52
San Jose 48
Santa Clara 43
Southend 37
Vienna 31
Fairfield 28
Beijing 26
Boardman 26
Los Angeles 25
Dallas 24
Tokyo 24
Chandler 22
Seattle 19
Bengaluru 18
Council Bluffs 16
Johannesburg 16
Dublin 14
Houston 14
Lauterbourg 14
Princeton 14
Abidjan 13
Milan 13
Frankfurt am Main 11
New York 11
Cambridge 9
Helsinki 9
Shanghai 9
Redondo Beach 8
Sofia 8
Wilmington 8
Woodbridge 8
Munich 7
Rome 7
Tongling 7
Turin 7
Baar 6
Da Nang 6
Guangzhou 6
Karbala 6
Naples 6
Ankara 5
Denver 5
Dhaka 5
Düsseldorf 5
Haiphong 5
London 5
Phoenix 5
Berlin 4
Castel Maggiore 4
Chennai 4
Hải Dương 4
Jakarta 4
Nuremberg 4
Quận Ba 4
Rimini 4
Shenzhen 4
Trento 4
Amman 3
Amsterdam 3
Ann Arbor 3
Atlanta 3
Biên Hòa 3
Boydton 3
Buffalo 3
Can Tho 3
Cesena 3
Chicago 3
Falkenstein 3
Genoa 3
Hillsboro 3
Lappeenranta 3
Leuna 3
Olalla 3
Padova 3
Paris 3
Phủ Lý 3
Portsmouth 3
Reggio Emilia 3
Riva del Garda 3
Riyadh 3
San Francisco 3
Toronto 3
Tân Tiến 3
Warsaw 3
Westminster 3
Wuhan 3
Algiers 2
Aracati 2
Baghdad 2
Belém 2
Brooklyn 2
Brussels 2
Calgary 2
Totale 1.647
Nome #
An all-natural, very low-calorie ketogenic diet (VLCKD) protocol has similar efficacy and safety to commercial meal replacements (whole or partial) in inducing weight loss: results from a prospective, controlled, 4-arm pragmatic trial (KOBE trial) 238
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 208
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? 185
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 171
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 171
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 165
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 156
Evidence-based medicine and the problem of healthy volunteers 156
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 152
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 147
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 140
Obesity and NAFLD: Same problem? 130
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 126
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 121
NASH: A glance at the landscape of pharmacological treatment 113
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease 108
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study 31
Totale 2.518
Categoria #
all - tutte 7.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 2 0 3
2021/2022119 3 12 6 0 8 6 3 8 12 6 35 20
2022/2023156 9 13 6 12 16 8 11 7 39 7 12 16
2023/2024119 16 14 6 4 10 19 2 10 6 19 2 11
2024/2025527 14 33 51 33 58 11 30 33 20 53 51 140
2025/20261.461 216 227 149 171 104 63 128 62 242 99 0 0
Totale 2.518